Amalgamated Bank Reduces Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Amalgamated Bank decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 5.8% during the 3rd quarter, HoldingsChannel reports. The fund owned 37,353 shares of the company’s stock after selling 2,280 shares during the quarter. Amalgamated Bank’s holdings in HCA Healthcare were worth $15,181,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the 2nd quarter worth $27,000. Unique Wealth Strategies LLC bought a new position in HCA Healthcare during the 2nd quarter worth approximately $28,000. Bangor Savings Bank raised its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC increased its stake in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at about $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $366.66 on Wednesday. The stock has a market capitalization of $92.87 billion, a PE ratio of 16.46, a price-to-earnings-growth ratio of 1.37 and a beta of 1.68. HCA Healthcare, Inc. has a 52 week low of $226.44 and a 52 week high of $417.14. The stock has a 50 day moving average price of $392.01 and a 200 day moving average price of $355.77. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.72%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HCA shares. TD Cowen decreased their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Truist Financial upped their price objective on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Finally, Oppenheimer raised their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $379.11.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.